Stealth BioTherapeutics

Stealth BioTherapeutics Receives FDA Accelerated Approval for Forzinity in Barth Syndrome

The U.S. Food and Drug Administration (FDA) granted accelerated approval to Stealth BioTherapeutics’ Forzinity (elamipretide)...